Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Watch Out for a Selloff in Vaxart Stock

By Chris Lau, InvestorPlace Contributor

Vaxart needs a Covid-19 vaccine approved and selling on the market before the established mega-cap names take all the sales.

Workhorse Stock Rallied, but It’s Clear There’s No Gas in That Tank

By Chris Lau, InvestorPlace Contributor

Workhorse is trading on the hope that the USPS lawsuit will revive the bidding review and earn a much-needed contract.

Nvidia Stock Isn’t Cheap, but It Still Is a Wise Buy on Future Growth

By Chris Lau, InvestorPlace Contributor

Nvidia products, from PC consumer markets to enterprise servers, are hotter than ever with growth accelerating after the Arm acquisition.

STEM Stock Offers a Triple Play on Clean Energy, Storage and AI

By Chris Lau, InvestorPlace Contributor

A steady stream of press releases increases STEM stock brand awareness in the clean energy community. The company is doing what no other competitor can do.

7 Reddit Penny Stocks for Your July Buy List

By Chris Lau, InvestorPlace Contributor

Reddit's retail crowd may buy these seven penny stocks whose sound business fundamentals and relative under-valuation will close the gap for tremendous upside.

Load More